BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35594442)

  • 1. Magnetic resonance spectroscopy shows associations between neurometabolite levels and perivascular space volume in Parkinson's disease: a pilot and feasibility study.
    Donahue EK; Bui V; Foreman RP; Duran JJ; Venkadesh S; Choupan J; Van Horn JD; Alger JR; Jakowec MW; Petzinger GM; O'Neill J
    Neuroreport; 2022 May; 33(7):291-296. PubMed ID: 35594442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and application of neurochemical profile by multiple regional
    Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
    Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
    Levin BE; Katzen HL; Maudsley A; Post J; Myerson C; Govind V; Nahab F; Scanlon B; Mittel A
    J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
    Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH
    Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical evaluation of brain function with 1H magnetic resonance spectroscopy in patients with fragile X syndrome.
    Utine GE; Akpınar B; Arslan U; Kiper PÖ; Volkan-Salancı B; Alanay Y; Aktaş D; Haliloğlu G; Oğuz KK; Boduroğlu K; Alikaşifoğlu M
    Am J Med Genet A; 2014 Jan; 164A(1):99-105. PubMed ID: 24259304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary motor area-related injury of anterior central gyrus in Parkinson's disease with dyskinesia: A study based on MRS and Q-space.
    Yuan M; Du N; Song Z
    Neurosci Lett; 2023 May; 805():137224. PubMed ID: 37019268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased perivascular space volume in white matter and basal ganglia is associated with cognition in Parkinson's Disease.
    Donahue EK; Foreman RP; Duran JJ; Jakowec MW; O'Neill J; Petkus AJ; Holschneider DP; Choupan J; Van Horn JD; Venkadesh S; Bayram E; Litvan I; Schiehser DM; Petzinger GM
    Brain Imaging Behav; 2024 Feb; 18(1):57-65. PubMed ID: 37855955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI): An In Vivo Proton Magnetic Resonance Spectroscopy (1H-MRS) Study.
    Veeramuthu V; Seow P; Narayanan V; Wong JHD; Tan LK; Hernowo AT; Ramli N
    Acad Radiol; 2018 Sep; 25(9):1167-1177. PubMed ID: 29449141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
    Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
    Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain morphological alterations and cellular metabolic changes in patients with generalized anxiety disorder: A combined DARTEL-based VBM and (1)H-MRS study.
    Moon CM; Jeong GW
    Magn Reson Imaging; 2016 May; 34(4):429-36. PubMed ID: 26708039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.
    Baik HM; Choe BY; Son BC; Jeun SS; Kim MC; Lee KS; Kim BS; Lee JM; Lee HK; Suh TS
    Eur J Radiol; 2003 Sep; 47(3):179-87. PubMed ID: 12927660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3 T.
    Chiu PW; Mak HK; Yau KK; Chan Q; Chang RC; Chu LW
    Age (Dordr); 2014 Feb; 36(1):251-64. PubMed ID: 23709317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
    Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
    Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study.
    Gazdzinski S; Millin R; Kaiser LG; Durazzo TC; Mueller SG; Weiner MW; Meyerhoff DJ
    Obesity (Silver Spring); 2010 Apr; 18(4):743-8. PubMed ID: 19816410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
    Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S
    Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.